A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Genomics is the large-scale study of entire genomes, including their sequence, structure, function, and evolution. Sanger sequencing (chain-termination method) was the gold standard for decades and sequenced the first human genome; next-generation sequencing (NGS) platforms can now sequence a human genome for a few hundred dollars in a day through massively parallel short-read approaches. Comparative genomics identifies conserved and divergent regions across species; functional genomics (RNA-seq, ChIP-seq) maps gene expression and regulatory elements globally. Bioinformatics tools assemble, align, and annotate the resulting sequence data, transforming raw reads into biological insight.
Trace a sequencing read from library preparation through base calling to alignment against a reference genome. Compare the Human Genome Project's timeline and cost to modern NGS to appreciate how technology transformed the field.
You already know how DNA is replicated and how PCR amplifies specific regions. Genomics extends this logic to the entire genome at once, asking: what is the complete DNA sequence of an organism, and what does that sequence do? The shift from studying one gene at a time to studying all genes simultaneously required both a technological revolution in sequencing and a parallel revolution in computation.
*Sanger sequencing*, developed in the 1970s, was the workhorse technology for decades. It works by incorporating chain-terminating dideoxynucleotides into a PCR-like reaction, producing a ladder of fragments of different lengths that can be separated by size to read the sequence. Sanger sequencing is accurate and still used for validating specific regions, but it sequences only one fragment at a time — making whole-genome sequencing by this method enormously slow and expensive. The Human Genome Project used Sanger sequencing and required 13 years and roughly $3 billion to produce the first human genome sequence (completed in 2003).
*Next-generation sequencing (NGS)* broke this bottleneck through massive parallelism. Instead of sequencing one fragment, NGS sequences millions of fragments simultaneously in a single flow cell run. DNA is sheared into short fragments, adapters are ligated to the ends, and the library is loaded onto a chip where each fragment is amplified and then sequenced in parallel. Because every fragment is sequenced at the same time, the throughput is millions of times greater than Sanger. A human genome now costs around $200–500 and takes a day. The tradeoff is read length — NGS reads are short (100–300 bp), which creates challenges for assembling repetitive regions.
Raw sequencing data is just a massive pile of short nucleotide strings. *Bioinformatics* — computational biology applied to sequence data — is what transforms that raw data into biological knowledge. Assembly algorithms stitch overlapping reads into contiguous sequences. Alignment tools map reads to a reference genome to identify variants. Annotation pipelines identify where genes, regulatory elements, and non-coding RNAs are located. *Functional genomics* tools like RNA-seq quantify gene expression across conditions; ChIP-seq maps where proteins bind the DNA genome-wide. Each of these produces different layers of understanding about what the genome is doing in a given cell or tissue.
A key misconception to leave behind: sequencing a genome is not the end of discovery, it is the beginning. Even with the complete sequence of the human genome, roughly 20% of protein-coding genes have no assigned function, and the regulatory landscape — which controls when and where genes are expressed — is still being mapped. The genome sequence is a reference; understanding it is a decades-long project of functional experiments, comparative analysis across species, and patient correlation with human disease.